Skip to main content
xMedica

Search

6 studies match these filters. Showing 1–6 of 6 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT01574053Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 183 sites in total · contact listed

RecruitingNot verified since Feb 1, 202435,000target183 / 202012Feb 28, 2024
NCT07326709A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

The purpose is to assess safety and tolerability of votoplam and to determine whether votoplam slows disease progression in patients with early symptomatic Huntington's disease (HD) compared to the control arm. HTT227 - current compound code (former code is PTC518 from PTC Therapeutics), HTT227 is…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 117 sites in total · contact listed

RecruitingPhase 3770target117 / 272026Sep 22, 2026
NCT07609108Pridopidine Phase 3 Study in Huntington's Disease

The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed

RecruitingPhase 3400target66 / 122026Nov 19, 2026
NCT05491525Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed

RecruitingPhase 2 / Phase 371target38 / 162022Jun 15, 2026
NCT07190300TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of this study is to evaluate the safety, tolerability, and efficacy of two different treatment combinations of tulmimetostat in participants with de novo or recurrent metastatic hormone-sensitive prostate cancer (mHSPC). Phase I aims to determine the recommended dose(s) for expansion (RD…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed

RecruitingPhase 1 / Phase 2181target31 / 142026Nov 13, 2026
NCT02402244Project: Every Child for Younger Patients With Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed

Recruiting75,000target279 / 62015Nov 19, 2026

Filters

Clear all filters